Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
SLXN

Price
2.15
Stock movement up
+0.42 (15.16%)
Company name
Biomotion Sciences Ordinary Shares
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
9.90M
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return (CAGR)
-99.97%
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Last updated: 2025-12-04

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

SLXN does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count3.13M
EPS (TTM)-6.65
FCF per share (TTM)-9.48

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)-11.00K
Operating income (TTM)-7.25M
Net income (TTM)-7.53M
EPS (TTM)-6.65
EPS (1y forward)-4.39

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash9.24M
Net receivables0.00
Total current assets11.05M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment468.00K
Total assets11.61M
Accounts payable946.00K
Short/Current long term debt485.00K
Total current liabilities2.79M
Total liabilities4.64M
Shareholder's equity6.98M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-10.73M
Capital expenditures (TTM)7.00K
Free cash flow (TTM)-10.74M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-107.94%
Return on Assets-64.85%
Return on Invested Capital-86.65%
Cash Return on Invested Capital-123.53%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open2.75
Daily high3.24
Daily low2.67
Daily Volume109K
All-time high41513.51
1y analyst estimate9.00
Beta-0.06
EPS (TTM)-6.65
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
SLXNS&P500
Current price drop from All-time high-99.99%-0.89%
Highest price drop-99.99%-19.00%
Date of highest drop21 Nov 20258 Apr 2025
Avg drop from high-93.76%-2.49%
Avg time to new high-6 days
Max time to new high290 days89 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
SLXN (Biomotion Sciences Ordinary Shares) company logo
Marketcap
9.90M
Marketcap category
Small-cap
Description
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
Employees
11
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner